title: Recent advances in childhood vitiligo.
abstract: Vitiligo is an autoimmune depigmentation disorder that is estimated to affect about .5% of the worldwide population. Half of all cases begin in childhood. A variety of advances occurred in the past two decades that have enhanced the management of childhood vitiligo. This contribution reviews recent advances in vitiligo, including a better understanding of the pathogenesis and autoimmune comorbidities, description of the psychological comorbidities, a broader range of therapeutic options.
authors.affiliation: Department of Dermatology, Mt. Sinai St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Avenue, Suite 11D, New York, NY 10025, USA. Electronic address: nsilverb@chpnet.org.
authors.forename: Nanette B
authors.initials: NB
authors.lastname: Silverberg
mesh_terms: D001327:Autoimmune Diseases / Q000150:complications*; D002648:Child; D002669:Child Welfare; D003937:Diagnosis, Differential; D006801:Humans; D014820:Vitiligo / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy